1. Quinones, L., A. Roco, J.P. Cayun, P. Escalante and C. Miranda et al., 2017. Farmacogenomica como herramienta fundamental para la medicina personalizada: aplicaciones in practica clinica. Rev. Med. Chile, 145: 483-500.
   CrossRef  |  Direct Link  |  
2. Torres, F.Z., I.L. Asseff, A. Lima, A. Reyes-Espinoza and V. Loera-Castaneda, 2016. Genetic polymorphisms associated to folate transport as predictors of increased risk for acute lymphoblastic leukemia in Mexican children. Front. Pharmacol., 10.3389/fphar.2016.00238.
   CrossRef  |  Direct Link  |  
3. Asseff, I.L., G.B. Gaucin, H.J. Olguin, J.A.G. Najera, A.T. Lopez, G.P. Guille and F.Z. Torres, 2016. Pharmacokinetics of ranitidine in preterm and term neonates with gastroesophageal reflux. BMC Pediatr., 10.1186/s12887-016-0630-x.
   CrossRef  |  Direct Link  |  
4. Zaruma-Torres, F., I.L. Asseff, A.R. Espinoza, V.L. Castaneda and I.C. Hernandez et al., 2015. Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with All. De Gruyter, 10.1515/dmpt-2015-0011.
   CrossRef  |  Direct Link  |  
5. Torres, F.L.Z., I.L. Asseff, A.R. Espinozal, V. Lopera-Castaneda, H.A. Reyes and M.C. Arias-Pelaez et al., 2015. Impact of genetic polymorphisms of the methotrexate metabolic pathway on the survival of Mexican children with All. Drug Metabol. Pers. Ther., 22: 177-187.
   CrossRef  |  Direct Link  |  
6. Asseff, I.L., M.S. Macias, M.C. Velasco, O.C. Arreola, F.Z. Torres, M.D. Carrasco-Portugal and F.J. Flores-Murrieta, 2014. OCT1 and OCT2 polymorphisms and their association with metformin population pharmacokinetics in Mexican patients with type 2 diabetes. Clin. Pharmacol. Drug Dev., 3: 23-24.